Delivery Order SPE2DB20D3101-SPE2DB22FH2Q5
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.77 delivery order contract is for the supply of 4563416288 diclofenac sodium extended-release 100 mg tablets. This award is not designated as a set-aside contract. The contract is a firm fixed-price delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,462.54, is for the delivery of 100 mg diclofenac sodium extended-release tablets. The contract is a firm-fixed-price delivery order with an ultimate completion date of October 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,205.34 firm-fixed-price delivery order is for 4,566,178,064 units of Diclofenac Potassium 50 mg tablets, to be delivered by October 23, 2024. The award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.58 firm fixed-price delivery order is for the supply of 4,559,130,960 tablets of diclofenac sodium delayed-release 75 mg. The contract has a completion date of November 18, 2022 and was awarded on November 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,700.71, is a delivery order contract for the supply of DICLOFENAC-MISOPROST 75-0.2 MG 60S pharmaceutical products. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,410.15 firm-fixed-price delivery order is for the supply of 4,565,879,521 units of Diclofenac Sodium Delayed-Release (EC) 25 mg tablets in 100-count bottles. The award has a completion date of September 20, 2024 and was made on September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,395.27, is for the delivery of 100 mg tablets of the drug diclofenac sodium extended-release. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 19, 2023. The contract is not designated with a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of DICLOFENAC POT 50 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $1,075.24 and a period of performance through February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,069.02, is for the delivery of DICLOFENAC SODIUM 1% GEL 50GM, with an ultimate completion date of October 31, 2024. This contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through...
- This federal contract award, valued at $1,493.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of 4,568,201,898 units of Diclofenac Sodium Delayed-Release 75 mg tablets. The contract has a firm fixed price and an ultimate completion date of May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FH2Q5Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,275.79 firm fixed-price delivery order is for the supply of 4555678570 DICLOFENAC SOD ER 100 MG TAB 100S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/10/21 |